Clinical trial
Scandinavian Cystic Fibrosis Azithromycin Study
NCT00411736 · Rigshospitalet, Denmark, Other · Completed
Key facts
| NCT number | NCT00411736 |
|---|---|
| Title | Scandinavian Cystic Fibrosis Azithromycin Study |
| Official title | Supplementary Oral Azithromycin in Treatment of Intermittent Pseudomonas Aeruginosa Colonization in CF-patients With Inhaled Colistin and Oral Ciprofloxacin; Postponing Next Isolate of Pseudomonas and Prevention of Chronic Infection. A Prospective, Double-blinded, Placebo-controlled Scandinavian… |
| Lead sponsor | Rigshospitalet, Denmark, Other |
| Collaborators | Cystic Fibrosis Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Study medication, azithromycin or placebo, Azithromycin or placebo tablets |
| Enrollment | 45 |
| Start date | May 1, 2008 |
| Primary completion | Dec 1, 2013 |
| Completion | Mar 1, 2014 |
| First posted | Dec 15, 2006 |
| Last update posted | Mar 14, 2014 |
| Countries | Denmark, Norway, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: